FountainVest Partners has closed its third China-focused fund at the hard cap of $2.1 billion after approximately six months in the market
Northern Light Venture Capital (NLVC) has led a $25 million Series B funding round for TenNor Therapeutics, a Chinese drug developer specializing in infectious diseases.
Qiming Venture Partners has invested an undisclosed sum in LIH Investment & Management, a Beijing-based healthcare company that specializes in providing rehabilitation services.
A spin-out from domestic pharmaceutical players Mensa Group, Indonesian healthcare services app HaloDoc wants to make medication and doctor consultations more accessible to the masses
Clermont Group, a Singapore-based private investment firm led by billionaire Richard Chandler, has led a Series A round worth $11 million for Indonesian healthcare services app HaloDoc.
Taiho Ventures, the newly established VC arm of Japan’s Taiho Pharmaceutical, has participated in a $70 million Series B round of funding for Arcus Biosciences, a US-based start-up that develops cancer drugs.
PremjiInvest, the family office of Wipro Group chairman Azim Premji, has invested in Indian online eyewear retailer Lenskart.
Venturecraft, a Singapore-based VC investor and accelerator, has launched a new S$50 million ($37 million) investment fund aimed at early and growth stage medical technology (medtech) and internet start-ups in Asia.
Executives from Ironbridge Capital and Catalyst Investment Managers team up with retail veteran Brett Blundy to take Australia's Mr Vitamins into its next stage of growth
Berry Genomics, a Chinese genetic test developer backed by Qiming Venture Partners and Legend Capital, is looking to list in Shenzhen through a reverse merger.
Apis Partners and ICICI Venture have invested in Indian health insurance provider Star Health & Allied Insurance.
Beijing Allcure Medical Technology, a Chinese medical start-up that develops cloud-based radiotherapy technology, has raised an extended Series A round of funding worth RMB180 million ($27 million).
Sequoia India and US-based Sands Capital Ventures have led a $27.4 million Series B round of funding for Mitra Biotech, an India and US-based company that focuses on personalized cancer therapies.
CVC Capital Partners has once again entered into a partnership with Indonesia’s Lippo Group, agreeing a IDR2.2 trillion ($165.7 million) deal to invest in Siloam International Hospitals, which is controlled by the Riady family-owned business.
Chinese healthcare-focused VC firm I-Bridge Capital has launched a joint venture (JV) with Israeli biopharmaceutical company BioLineRx that will target cross-border penetration of Chinese markets.
Quadrant Private Equity has acquired a majority stake in Injury Treatment, an Australia-based provider of injury prevention and rehabilitation services to employers and insurers, for an undisclosed sum.
Chinese mobile healthcare services provider Shanghai KingYee and its independent unit Quyiyuan - which operates a medical services booking app - have raised a combined RMB313 million ($47 million) in their latest rounds of funding.
SeaLink Capital Partners and the International Finance Corporation have committed a INR 1 billion ($14.9 million) Series C round to India-based dialysis clinic chain NephroPlus.
Indian pharmaceutical products developer Laurus Labs has filed for a domestic IPO, offering a partial exit for backers Warburg Pincus and Eight Roads Ventures.
Indian biopharmaceutical company Vyome Biosciences has raised a $14 million Series C funding round led by US investors Perceptive Advisors and Romulus Capital.
A US-based healthcare fund backed by Microsoft founder Bill Gates has led a A$4.5 million ($3.5 million) investment round in Australian medical technology company Atomo Diagnostics.
WestBridge Capital Partners has led a $15.6 million Series A round of funding for Innovaccer, a healthcare-focused IT outsourcing start-up with bases in Palo Alto and New Delhi.
Singapore’s Golden Gate Ventures has committed $2.5 million to a Series A funding round for Indonesian healthcare information portal operator Alodokter.
The Australian government has seeded $250 million ($191 million) from its Medical Research Future Fund (MRFF) to a biomedical technology-focused venture investment vehicle. It will match private sector commitments, bringing the total available for deployment...